Astelin

Quick links to important sections

Astelin

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Astelin

Quick Facts About Astelin

Property Description
Active Ingredient Azelastine Hydrochloride
Form Nasal Spray Solution
Pharmacological Class H1-receptor Antagonist (Antihistamine)
Common Use Relief of Seasonal and Non-Allergic Rhinitis Symptoms
Origin Synthetic

What is Astelin and What is it Used For?

Astelin is a prescription nasal spray solution indicated for relieving the symptoms of both seasonal allergic rhinitis (hay fever) and non-allergic vasomotor rhinitis. The medication is delivered via the intranasal route, a method clinically recognized for delivering medication directly to the affected nasal lining, allowing for targeted relief of symptoms like sneezing, runny nose, and nasal itch.

Its therapeutic purpose is to control and minimize the chronic discomfort associated with these conditions. Unlike many common antihistamines taken by mouth, Astelin is differentiated by its local administration, which is recognized for the efficacy of azelastine nasal spray in the management of allergic rhinitis symptoms.

What is the main ingredient in Astelin?

The active ingredient in this medication is Azelastine Hydrochloride, which is classified as an H1-receptor antagonist, belonging to the larger pharmacological class of antihistamines. Azelastine Hydrochloride is a synthetically derived compound, ensuring precise manufacturing control over the active substance.

This specific drug is often used when a patient requires targeted relief, as its nasal spray form acts directly where symptoms occur. Azelastine Hydrochloride is the active compound in Astelin, supporting its established role in the treatment landscape for rhinitis. The medication is formulated as a metered-spray solution, providing a consistent dose for efficient localized action.

What side effects are possible with Astelin?

Possible Side Effects and Safety Information

The safety profile for Astelin (Azelastine Hydrochloride Nasal Spray) is established through official regulatory documentation, classifying potential adverse reactions by both frequency and the body system affected. All documented effects and constraints are based strictly on data from controlled clinical trials and postmarketing experience, as detailed by health authorities such as the FDA and EMA.


Adverse Reactions by Classification

The most frequently reported adverse effect is dysgeusia, often described as a bitter taste, which is categorized as very common in some regulatory documents. Common side effects include those related to the central nervous system, such as somnolence (drowsiness) and headache, along with local effects like nasal discomfort (burning, stinging) and epistaxis (nosebleeds).

Adverse reactions are grouped by system-organ class, with effects noted in the Nervous System (e.g., dizziness, somnolence), Gastrointestinal Disorders (e.g., nausea, dry mouth), and Respiratory, Thoracic, and Mediastinal Disorders (e.g., pharyngitis, sneezing).

Serious Reactions and Safety Constraints

While rare, anaphylactoid reactions and other hypersensitivity reactions are documented serious events noted in postmarketing surveillance. A key regulatory safety constraint warns that somnolence may occur, cautioning against activities requiring complete mental alertness, such as driving or operating machinery. Furthermore, the official prescribing information includes a high-level safety note against concurrent use with alcohol or other CNS depressants, which may exacerbate impaired performance. For pregnancy, the medication is categorized with a statement indicating use is warranted only if potential benefits justify the potential risks.

Overdose and Emergency Response

Astelin Overdose and When to Seek Help

Official regulatory documents define the overdose profile for Azelastine Hydrochloride Nasal Spray by noting that overdosage reactions are not anticipated when the product is used via the prescribed intranasal route. However, regulatory information addresses the potential effects of high systemic exposure, such as those that may follow accidental oral ingestion.

Documented Manifestations and Scope

Overdose information, derived from studies at toxic oral doses, indicates that high systemic levels may produce central nervous system (CNS) effects. These documented manifestations include signs such as excitation and tremor, with the potential for convulsions also noted. The physiological system primarily affected in this context is the CNS.

Mandatory Emergency Action

The specific scenario that mandates an immediate response is the accidental ingestion by a child. In this situation, individuals are required to seek medical help immediately or call a poison control center immediately. If an overdose is suspected or the product is accidentally swallowed, the patient must proceed to the nearest hospital emergency room without delay.

Management Procedures

For management, official documentation states that symptomatic and supportive treatment should be instigated. As a procedural measure, gastric lavage is recommended if the overdose is determined to be recent. The prescribing information confirms that no specific antidote is known for Azelastine Hydrochloride.

Therapeutic Uses of Astelin

What Astelin Treats: Main Uses and Benefits

Astelin is considered relevant in situations involving certain distressing symptoms associated with allergic rhinitis and non-allergic conditions. The medication is commonly used across conditions presenting with acute episodes related to seasonal allergic rhinitis (hay fever), and it is applicable in conditions characterized by periods of heightened symptoms from perennial allergic rhinitis and non-allergic vasomotor rhinitis.

The primary therapeutic focus is on addressing symptom clusters that may become intense or disruptive, such as frequent sneezing, bothersome nasal itching, persistent nasal congestion, and a runny nose. The medication supports the patient during difficult episodes by easing distress across multiple symptom axes, including associated post-nasal drip and itchy, watery eyes.

“Applied in contexts where additional symptomatic support is needed, Astelin helps maintain a sense of stability when nasal and ocular symptoms become more noticeable.”

This assists with maintaining functional stability when symptoms interfere with routine activities, which contributes to improved day-to-day comfort during symptomatic periods.

Quick Fact: Relief for Nasal and Ocular Symptoms
Primary Indication Clusters Seasonal, perennial, and non-allergic rhinitis.
Symptoms Addressed Sneezing, runny nose, itching, congestion, and watery eyes.
Clinical Context Used during episodes of heightened symptoms and chronic discomfort.

Eligibility and Restrictions for Use

Who Can and Cannot Use Astelin?

The population eligibility for Azelastine Hydrochloride (Astelin) is strictly defined by regulatory authorities based on age, hypersensitivity, and physiological status.

Contraindications and Absolute Restrictions

The medicine is contraindicated and must not be used by individuals with a known hypersensitivity (an allergic reaction) to azelastine hydrochloride or to any of the other components in the nasal spray formulation.


Age-Based Eligibility Rules

Official approval for use is determined by the patient’s age and the specific condition being addressed:

  • For Seasonal Allergic Rhinitis (SAR), the medicine is approved for patients 5 years of age and older. Use is not established in children younger than 5 years.
  • For Vasomotor Rhinitis (VAR), the medicine is approved for patients 12 years of age and older. Use is not established in children younger than 12 years for this indication.

Conditional Use and Status Restrictions

Use is subject to specific constraints based on a patient’s condition, requiring prior consultation with a health professional:

  • Pregnancy and Lactation: Individuals who are pregnant or breastfeeding must consult a health professional before use. Regulatory data is inadequate to assess drug-related risk during pregnancy, and the compound is excreted into human milk.
  • Local Anatomical Conditions: Patients with recent nose ulcers, nose surgery, or nose injury that has not fully healed are directed to seek medical consultation prior to using the medicine.
  • Comorbidity Considerations: While no specific limits are set for older adults, caution is noted for those with potential age-related kidney or liver problems that may affect the drug's clearance.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Pharmacodynamic Interactions

Co-administration with alcohol and other Central Nervous System (CNS) depressants is documented to result in a significant additive pharmacodynamic effect. This interaction can lead to further reductions in alertness and increased impairment of CNS performance, and regulatory documentation explicitly states that the concurrent use of these substances should be avoided.


Pharmacokinetic Interactions and Exposure Alteration

Specific studies highlight a pharmacokinetic interaction pattern concerning the systemic clearance of azelastine. The co-administration of Cimetidine, a non-specific inhibitor of hepatic enzymes, significantly increases the systemic exposure of azelastine. In controlled regulatory studies, the mean maximum plasma concentration (Cmax) and Area Under the Curve (AUC) of azelastine were found to be increased by approximately 65%.

Conversely, co-administration with other substances tested, such as Ranitidine and Erythromycin, resulted in no significant effect on the pharmacokinetics or systemic exposure of azelastine.


Population-Specific Clearance Cautions

Interaction severity and drug effects may be influenced by patient condition. Patients with renal impairment (kidney disease) are noted to potentially experience increased effects of azelastine due to a documented slower rate of removal of the medicine from the body. This condition requires caution related to potential exposure modification.

Mechanism of Action

How Astelin Works: Pharmacological Mechanism

Astelin (azelastine) operates through a multi-targeted mechanism, primarily acting as a selective Histamine H1-receptor antagonist. This action involves competitive binding to the H1-receptors, thereby suppressing signaling sequences mediated by histamine. The resulting physiological effect is the stabilizing of overactive physiological responses, which reduces the biological effects of endogenous histamine on target tissues.

Astelin also exhibits mast cell stabilization properties. It engages mechanisms that regulate overactive cellular processes by influencing the integrity of mast cells, reducing the degranulation and subsequent release of histamine and other pro-inflammatory mediators. By modifying early molecular steps, azelastine induces modulation within targeted inflammatory pathways.

Furthermore, the compound modulates key pathways associated with heightened physiological responses through the inhibition of various inflammatory substances, including leukotrienes and certain cytokines. This multi-target effect leads to predictable physiological adjustments by limiting the overall inflammatory cascade.

Dosage and Administration Information

Astelin (azelastine hydrochloride) is an antihistamine nasal spray for intranasal use only. It is prescribed for the treatment of symptoms associated with seasonal and perennial allergic rhinitis, as well as vasomotor rhinitis, in specific age groups.

General Administration Instructions

  1. Priming: Before initial use, or if the spray has not been used for three or more days, the pump must be primed by releasing 4 to 6 test sprays into the air until a fine mist appears. This ensures the correct dose is delivered.
  2. Preparation: Gently blow your nose to clear the nostrils. Keep your head tilted slightly downward toward your toes.
  3. Dosing: Insert the spray tip about 1/4 to 1/2 inch into one nostril. Close the other nostril with a finger. Press the pump firmly once while gently sniffing simultaneously. Repeat the process in the other nostril.
  4. Post-Dose: After administration, gently breathe in. Avoid tilting your head back immediately, as this may lead to a bitter taste if the medication runs into the throat. Wipe the nozzle with a clean, dry tissue and replace the safety cap.

Do not spray Astelin into your eyes. If a dose is missed, administer it as soon as remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped. Do not double the dose to compensate for a missed one.

Recommended Dosing for Astelin

Dosage is determined by the patient's age and the condition being treated. Always adhere to the specific dosing instructions provided by your healthcare provider.

Condition Age Group Recommended Dose Frequency
Seasonal Allergic Rhinitis Adults & Adolescents (12+) 1 or 2 sprays per nostril Twice Daily
Pediatric (5-11 years) 1 spray per nostril Twice Daily
Vasomotor Rhinitis Adults & Adolescents (12+) 2 sprays per nostril Twice Daily

Recent Clinical Evidence

Research evidence / Overview of Studies for Astelin


Evidence for Use in Seasonal Allergic Rhinitis (Hay Fever)

The research for seasonal allergic rhinitis (hay fever) was primarily built upon a large number of short-term, randomized controlled trials (RCTs), including double-blind and placebo-controlled designs. These studies were used in research exploring how symptoms change over time during a typical allergy season. Researchers focused on outcomes related to physical discomfort, specifically tracking changes in symptom groups like sneezing, runny nose, and nasal itch, which are relevant in evidence describing how symptoms are measured.

Studies reported measured differences in symptom scores when comparing the medication to a placebo across the short-term trial periods. Reports described patterns related to the medication's intended evaluation of core nasal symptoms and associated eye symptoms. This body of evidence contributes to the broader evidence landscape for conditions characterized by fluctuating or episodic manifestations.


Evidence for Use in Perennial and Non-Allergic Rhinitis

Research also examined Astelin for patients with perennial (year-round) allergic rhinitis, a condition where symptoms may vary in intensity. For this indication, studies explored symptom relief over intermediate treatment periods, typically lasting four to six weeks. As with seasonal allergies, research was conducted during periods of increased symptom activity.

For non-allergic vasomotor rhinitis (VMR), a condition where allergic triggers are absent, studies were also conducted during periods of increased symptom activity. Research examined temporary physiological imbalance related to non-allergic nasal issues in adults. Findings indicate that measured changes in symptom scores was observed in some studies when comparing the medication to a placebo across these specific trial periods.


Long-Term Study Follow-up and Durability of Evidence

Research on Astelin primarily focuses on short-term or intermediate periods. Follow-up durations were limited in the core efficacy trials for both seasonal and non-allergic rhinitis.

Longer follow-up has been conducted, but it has been mainly used to monitor the overall tolerability and safety profile rather than to track the sustained assessment of symptoms over many months. Therefore, while studies describe how symptoms evolved in the observed populations during the initial trial weeks, there is limited information for long-term outcomes or the durability of the medication's intended effect over a full year of continuous or intermittent use.


Areas of Research Uncertainty and Study Limitations

Follow-up durations were limited in the core efficacy measurements, meaning that long-term effects are not fully established across the indications. Additionally, the evidence quality varies across studies, particularly for non-allergic rhinitis, where the population is less uniform, and sample sizes were limited. These study results reflect the specific conditions under which they were conducted and findings describe group patterns, not personal outcomes. Comparative evidence is lacking, meaning that research is ongoing to fully contextualize the medication within the evolving evidence landscape.

Key Studies & References

  1. Azelastine Hydrochloride Nasal Spray Drug Information (Official Label Overview)
  2. Azelastine nasal spray in the treatment of perennial allergic rhinitis (Review of Efficacy Data)

Frequently Asked Questions (FAQ)

Common questions about Astelin (FAQ)

Q: Does Astelin cause drowsiness or fatigue?

According to official product information, somnolence (drowsiness) and fatigue are both classified as common adverse reactions reported in clinical trials. Official safety constraints caution that activities requiring complete mental alertness, such as driving, may be affected.

Q: What are the most common side effects of Astelin?

Regulatory documents list several common side effects observed in clinical studies. These frequently reported effects include bitter taste (dysgeusia), somnolence (drowsiness), headache, nasal discomfort (such as burning or stinging), and nosebleeds (epistaxis).

Q: Can Astelin change my sense of taste or smell?

A change in the sense of taste, commonly described as a bitter taste (dysgeusia), is a very frequent side effect noted in regulatory safety data. Official product information emphasizes the bitter taste effect, which is classified as very frequent.

Q: Can Astelin be used by children?

Official approval for use is strictly defined by age and the condition being treated. For seasonal allergic rhinitis, the medicine is approved for patients 5 years of age and older. For vasomotor rhinitis (a non-allergic condition), it is approved only for patients 12 years of age and older.

Q: What age group is Astelin approved for?

The medication’s official approval covers different age groups depending on the indication. It is approved for patients aged 5 years and older for seasonal allergic rhinitis, and for patients aged 12 years and older for vasomotor rhinitis.

Q: Can I drive or operate machinery after using Astelin?

Official safety constraints caution that activities requiring complete mental alertness, such as driving or operating machinery, may be affected due to the potential for somnolence (drowsiness). This warning is based on somnolence being a reported side effect.

Q: Why do some people experience dry mouth with Astelin?

Dry mouth (xerostomia) is an adverse reaction reported in clinical trials. This is an adverse reaction reported in clinical trials. It is associated with the medication’s properties as an H1-receptor antagonist.

Q: Is it normal to feel a bitter taste after using Astelin?

Yes, a bitter taste (dysgeusia) is frequently experienced by users. This effect is classified as a very common adverse effect in official regulatory documents, meaning it is one of the most often reported side effects.

Q: How is Astelin different from a steroid nasal spray like Flonase?

Astelin belongs to a different pharmacological class than steroid nasal sprays. Astelin is classified as an H1-receptor antagonist (antihistamine), meaning it works by blocking the effects of histamine. Steroid nasal sprays, such as fluticasone, are corticosteroids that work primarily by reducing inflammation.

Q: How quickly can I expect Astelin to start working?

Clinical trial results describe that a measured decrease in symptoms, compared to placebo, reached significance within 3 hours after the initial dose. This time frame reflects the intended onset of action for the medication.

Q: How long do the effects of Astelin typically last?

Studies conducted on the twice-daily dosing regimen indicated that the intended improvement in symptoms was observed to persist over the 12-hour dosing interval. This is consistent with the drug’s established dosing interval.

Q: Can Astelin be used for non-allergic congestion?

Yes, Astelin is officially indicated for the treatment of symptoms associated with vasomotor rhinitis (VMR). VMR is a non-allergic condition whose symptoms, including nasal congestion, are indications for use.

Q: Is Astelin a daily medication or only used when needed?

The official documentation describes a consistent, daily treatment regimen rather than an on-demand use. This regimen is typically intended for managing chronic or recurring symptoms.

Q: Can I use Astelin for a long period of time?

Core efficacy studies were based on short-term or intermediate periods of use, such as trials lasting up to 8 weeks. While some safety data monitored tolerability for longer periods, official documents note that there is limited information regarding the long-term outcomes of continuous use over extended periods.

Q: Can I become dependent on Astelin?

Astelin is not classified as an addictive substance. However, an adverse reaction reported in regulatory literature is tolerance, which is a reduced response to the drug’s effects over time with continued use.

Q: What happens if I stop using Astelin suddenly?

Stopping the medication will remove its therapeutic effect. This may lead to a return of the rhinitis symptoms that the medication was intended to control.

Q: Does using Astelin cause nosebleeds?

Yes, regulatory documents list epistaxis (nosebleeds) as a common local adverse effect that has been reported in clinical trials by users of the nasal spray.

Q: Is Astelin available over the counter?

Astelin (azelastine hydrochloride 0.1% nasal spray) is classified as a prescription-only medication. This means it requires authorization from a healthcare provider for its use.

Q: Are there different strengths of the Astelin nasal spray?

The Astelin nasal spray (azelastine hydrochloride 0.1%) is formulated to deliver 137 micrograms per spray. This is the standard strength for the Astelin brand.

Q: Has Astelin been studied in older adults?

Specific efficacy studies focused solely on the geriatric population (over 65) have not been conducted. However, pharmacokinetic studies suggested that age does not significantly influence how the medicine is processed or removed from the body.

Q: Is it okay if a small amount of Astelin drips out of my nose after spraying?

Patient instructions are specific about post-dosing technique, advising users to avoid tilting the head back to prevent the medicine from running into the throat, which can cause a bitter taste. Loss of drug volume may reduce the intended localized effect.

Q: Does Astelin need to be shaken before use?

Official instructions for the use of the Astelin 0.1% nasal spray do not explicitly state that the bottle must be shaken before each use. Instructions focus on priming the pump before initial use or after a period of non-use.

Q: Does Astelin affect blood pressure or heart rate?

A specific study on the heart’s electrical activity (QTc interval) showed no evidence of a significant effect when the medication was used at the recommended dose. This information is available in the official product documents.

Q: Can Astelin cause headaches?

Yes, headache is classified as a common adverse effect reported in regulatory documents based on data from clinical trials.

Q: Is Astelin effective for perennial allergies?

Yes, Astelin is officially indicated for the treatment of symptoms associated with perennial allergic rhinitis, which refers to year-round allergies.

Q: What research evidence supports the use of Astelin?

The support for the drug's use is based on the findings of randomized, placebo-controlled clinical trials. These studies compared the medication against a placebo and demonstrated measured differences in symptom scores across patients with seasonal and perennial allergic rhinitis.

Q: Can Astelin affect sleep or cause insomnia?

Adverse effects related to the Nervous System include somnolence (drowsiness) and fatigue. Drowsiness is common. Insomnia (difficulty sleeping) has also been reported in regulatory surveillance.

Q: Does Astelin contain preservatives?

Yes, the formulation contains benzalkonium chloride. This substance is included as a preservative in the nasal spray solution.

Q: What is the main difference between Astelin and Astepro?

Both contain the active ingredient azelastine, but Astelin is the 0.1% strength, while Astepro is available in both 0.1% and 0.15% strengths. Astepro also contains additional inactive ingredients that are included to help mask the bitter taste often associated with azelastine.

Q: Are there any rare but serious side effects associated with Astelin?

Yes, rare but serious events have been noted in postmarketing surveillance. These include anaphylactoid reactions and other hypersensitivity reactions, which are signs of a severe allergic response.

Q: Does Astelin interact with herbal supplements?

The official label specifically warns against co-administration with other Central Nervous System (CNS) depressants. Patients are generally advised to inform their healthcare provider about any medicines or supplements they are currently using.

Q: What is known about the long-term safety of Astelin?

The core efficacy and safety research primarily focused on short-term or intermediate periods of use. While long-term follow-up has been conducted mainly to monitor overall tolerability, official documentation indicates that the long-term effects are not fully established or described for continuous use over a full year.

Q: Does Astelin help with post-nasal drip?

Yes, Astelin is officially indicated for the treatment of symptoms associated with vasomotor rhinitis, which includes the relief of post-nasal drip (also referred to as postnasal drainage).

Q: What are the signs of an allergic reaction to Astelin?

Serious reactions noted in regulatory data involve hypersensitivity and anaphylactoid reactions. Signs of a severe allergic response can typically involve symptoms like swelling (angioedema), hives, rash, or difficulty breathing.

How should Astelin be stored and disposed of?

Astelin (azelastine hydrochloride) Nasal Spray must be stored according to regulatory requirements to ensure product stability and safety.

Official Storage Requirements

Detail Regulatory Requirement
Temperature Store at controlled room temperature (20 C to 25 C / 68 F to 77 F).
Handling Protect from freezing. Store the container in an upright position.
Container Keep the container tightly closed and store it in its original carton.
Child Safety Must be kept out of the reach of children.

Disposal Instructions

For proper disposal, patients should consult a healthcare professional or contact a local Poison Control Center about how to safely discard any unused or expired medication. Unused medicines should generally not be flushed down a toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Astelin found in:

A-Z Index: